In addition, high tau burden is associated with more rapid clinical progression and cognitive decline in subjects with MCI, which is associated with tau protein deposition, and has been shown to correlate more closely with dementia severity than amyloid burden [30]. The gene discussed is MAPT; the disease is dementia.